Department of Endocrinology and Inherited Metabolic Disease, Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital/Zhengzhou Children's Hospital, Zhengzhou 450000, China
Abstract：Objective To study the relationship between serum microRNA-122 (miR-122) and insulin resistance in obese children. Methods Forty-seven children with severely obesity aged 7-14 years and 45 age-and gender matched healthy children with normal weight (control group) were enrolled. The levels of height, weight, waistline, hip circumference, fasting blood glucose (FBG), fasting insulin (FINS), triglyceride (TG), total cholesterol (TC), free fatty acid (FFA), interleukin-6 (IL-6) and miR-122 in the two groups were measured. Body mass index (BMI), waist-hip ratio (WHR) and insulin resistance index (HOMA-IR) were calculated. Results Compared with the control group, the height, weight, BMI, WHR, FINS, HOMA-IR, TG, FFA, IL-6, and miR-122 levels in the obese group were significantly increased (P r=0.408, 0.442, and 0.464 respectively, P b'=0.318, P Conclusions The elevated serum miR-122 levels may be correlated with insulin resistance in obese children. The mechanism needs to be further studied.
CHEN Qiong,ZHANG Yao-Dong,WU Sheng-Nan et al. Correlation between serum microRNA-122 and insulin resistance in obese children[J]. CJCP, 2019, 21(9): 910-914.
Liu JM, Ye R, Li S, et al. Prevalence of overweight/obesity in Chinese children[J]. Arch Med Res, 2007, 38(8):882-886.
[2]
Willeit P, Skroblin P, Moschen AR, et al. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes[J]. Diabetes, 2017, 66(2):347-357.
[3]
Wang R, Hong J, Cao Y, et al. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults[J]. Eur J Endocrinol, 2015, 172(3):291-300.
[4]
Shah R, Murthy V, Pacold M, et al. Extracellular RNAs are associated with insulin resistance and metabolic phenotypes[J]. Diabetes Care, 2017, 40(4):546-553.
[5]
Ortega FJ, Mercader JM, Catalán V, et al. Targeting the circulating microRNA signature of obesity[J]. Clin Chem, 2013, 59(5):781-792.
Nakamura M, Kanda T, Sasaki R, et al. MicroRNA-122 inhibits the production of inflammatory cytokines by targeting the PKR activator PACT in Human Hepatic Stellate Cells[J]. PLoS One, 2015, 10(12):e0144295.
Lee JM, Okumura MJ, Davis MM, et al. Prevalence and determinants of insulin resistance among U.S. adolescents:a population-based study[J]. Diabetes Care, 2006, 29(11):2427-2432.
[10]
Iliopoulos D, Drosatos K, Hiyama Y, et al. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism[J]. J Lipid Res, 2010, 51(6):1513-1523.
[11]
Wu GY, Rui C, Chen JQ, et al. MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via Yin Yang 1[J]. Cell Physiol Biochem, 2017, 44(4):1651-1664.
[12]
Dong L, Hou X, Liu F, et al. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells[J]. Cell Biol Int, 2019, 43(5):553-564.
[13]
Röhl M, Pasparakis M, Baudler S, et al. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance[J]. J Clin Invest, 2004, 113(3):474-481.
